Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Key Points

• To evaluate whether an intensive lipid-lowering statin regimen provides greater protection against death and major cardiovascular events compared with a standard regimen following acute coronary syndromes.
• Evaluated patients with recent acute coronary syndromes receiving either an intensive or standard lipid-lowering statin regimen.
• Assessed outcomes including death, major cardiovascular events, and LDL cholesterol reduction.
• Intensive statin therapy provided significantly greater protection against death or major cardiovascular events compared to a standard moderate regimen.
• Early and continuous lowering of LDL cholesterol to levels substantially below standard targets conferred superior clinical protection.